Concurrent hyperbaric oxygen therapy and intratympanic steroid application as salvage therapy after severe sudden sensorineural hearing loss.

What Researchers Did

Researchers investigated the concurrent use of hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) as a salvage therapy for severe sudden sensorineural hearing loss (SSNHL).

What They Found

They found that concurrent hyperbaric oxygen therapy (HBOT) and intratympanic steroid application (ITS) were beneficial as a salvage therapy for therapy-refractory sudden sensorineural hearing loss (SSNHL). These findings encourage further investigation into this combined treatment for noise-induced and idiopathic SSNHL, including long-term or therapy-refractory cases.

Canadian Relevance

This study does not have a direct Canadian connection.

Study Limitations

A key limitation is that the abstract does not provide details on study design or sample size, which are crucial for assessing the generalizability of the findings.